JP3066502B1 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
JP3066502B1
JP3066502B1 JP11320437A JP32043799A JP3066502B1 JP 3066502 B1 JP3066502 B1 JP 3066502B1 JP 11320437 A JP11320437 A JP 11320437A JP 32043799 A JP32043799 A JP 32043799A JP 3066502 B1 JP3066502 B1 JP 3066502B1
Authority
JP
Japan
Prior art keywords
lys
multide
arg
ser
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP11320437A
Other languages
Japanese (ja)
Other versions
JP2001139598A (en
Inventor
康 茂里
昇 湯元
茂 竹谷
敦彦 石田
勇 亀下
仁 藤澤
Original Assignee
工業技術院長
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 工業技術院長 filed Critical 工業技術院長
Priority to JP11320437A priority Critical patent/JP3066502B1/en
Application granted granted Critical
Publication of JP3066502B1 publication Critical patent/JP3066502B1/en
Publication of JP2001139598A publication Critical patent/JP2001139598A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

【要約】 【課題】リン酸化コンセンサス配列を有するポリペプチ
ド及びそれを用いたSer/Thr蛋白質リン酸化酵素の活性
の同時検出及びスクリーニング方法の提供。 【解決手段】Lys Lys Arg Lys Ser Ser Leu Arg Arg Tr
p Ser Pro Leu Thr ProArg Gln Met Ser Phe Asp Cysで
表されるポリペプチド及びその類似ポリペプチド、該ポ
リペプチドとポリアミノ酸とのペプチドコンジュゲー
ト。
The present invention provides a polypeptide having a phosphorylation consensus sequence and a method for simultaneous detection and screening of the activity of a Ser / Thr protein kinase using the same. [Solution] Lys Lys Arg Lys Ser Ser Leu Arg Arg Tr
p Polypeptide represented by Ser Pro Leu Thr ProArg Gln Met Ser Phe Asp Cys and its analogous polypeptides, and peptide conjugates of the polypeptide and polyamino acids.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、リン酸化コンセン
サス配列を有するポリペプチド及びペプチドコンジュゲ
ート及びそれを用いたSer/Thr蛋白質リン酸化酵素の活
性の同時検出及びスクリーニング方法に関する。
[0001] The present invention relates to a polypeptide and a peptide conjugate having a phosphorylation consensus sequence and a method for simultaneous detection and screening of Ser / Thr protein kinase activity using the same.

【0002】[0002]

【従来の技術】一般に細胞外から細胞内に伝達される刺
激は、細胞膜上の受容体やチャンネル蛋白質などを活性
化し、次いで細胞内に伝達され、カルシウムイオンやcA
MPなどのセカンドメッセンジャーの産生を引き起こす。
その後各種蛋白質リン酸化酵素の活性化及び不活性化が
起こり、ターゲットとなる蛋白質のリン酸化や脱リン酸
化が引き起こされる(Cano,E., and Mahadevan, L. (19
95)Parallel signal processing among mammalian MAPK
s. Trends Biochem. Sci. 20, 117-122)。例えば、Ser
/Thr蛋白質リン酸化酵素の一つであるMAPKを含む一連の
蛋白質リン酸化酵素のカスケードは、細胞の増殖シグナ
ルがONになると活性化が起こることが知られている。
2. Description of the Related Art In general, a stimulus transmitted from the outside of a cell to an intracellular cell activates a receptor or a channel protein on a cell membrane, and then is transmitted into the cell to cause calcium ions or cA.
Causes the production of second messengers such as MP.
Thereafter, activation and inactivation of various protein kinases occur, causing phosphorylation and dephosphorylation of the target protein (Cano, E., and Mahadevan, L. (19).
95) Parallel signal processing among mammalian MAPK
s. Trends Biochem. Sci. 20, 117-122). For example, Ser
It is known that the cascade of a series of protein kinases including MAPK, one of the / Thr protein kinases, is activated when the cell growth signal is turned on.

【0003】今までに発見された蛋白質リン酸化酵素は
そのターゲットとなる蛋白質基質以外に、特異的なペプ
チド基質を用いて、その性質や機能解明が行われてき
た。例えば、CaMKIIの特異的基質のAutocamtide-2やPKA
の特異的基質であるKemptideなどがそれである。しか
し、これらの特異的基質を使用している限り、ある特定
の蛋白質リン酸化酵素の活性しか検出できないという欠
点がある。一方、ゲル内リン酸化法(Kameshita, I. an
d Fujisawa, H. (1989)A sensitive method for detect
ion of calmodulin-dependent protein kinase II acti
vity in sodium dodecyl sulfate-polyacrylamide gel.
Anal. Biochem. 183, 139-143; Kameshita, I. and F
ujisawa, H. (1996)Detection of protein kinase acti
vities toward oligopeptides in sodium dodecyl sulf
ate-polyacrylamide gel. Anal. Biochem. 237, 198-20
3)は粗抽出液のレベルで各種蛋白質リン酸化酵素の活
性をその分子量とともに簡便に検出できるので、蛋白質
リン酸化が関与する細胞内情報伝達機構の解析に必須の
手法として広く利用されている。
[0003] The properties and functions of the protein kinases discovered so far have been elucidated using specific peptide substrates in addition to the target protein substrates. For example, CaMKII specific substrates Autocamtide-2 and PKA
Kemptide, which is a specific substrate of E.g. However, as long as these specific substrates are used, there is a disadvantage that only the activity of a specific protein kinase can be detected. On the other hand, the in-gel phosphorylation method (Kameshita, I. an
d Fujisawa, H. (1989) A sensitive method for detect
ion of calmodulin-dependent protein kinase II acti
vity in sodium dodecyl sulfate-polyacrylamide gel.
Anal. Biochem. 183, 139-143; Kameshita, I. and F
ujisawa, H. (1996) Detection of protein kinase acti
vities toward oligopeptides in sodium dodecyl sulf
ate-polyacrylamide gel.Analyte. Biochem. 237, 198-20
3) is widely used as an indispensable technique for analyzing intracellular signal transduction mechanisms involved in protein phosphorylation, since the activity of various protein kinases can be easily detected together with their molecular weights at the level of crude extracts.

【0004】ゲル内リン酸化法に用いる基質としては従
来はミエリン塩基性蛋白質などの蛋白基質が主流であっ
たが、最近の改良(Kameshita, I. and Fujisawa, H.
(1996)Detection of protein kinase activities towar
d oligopeptides in sodium dodecyl sulfate-polyacry
lamide gel. Anal. Biochem. 237, 198-203)により基
質となるペプチドをポリリジンなどアミノ酸ポリマーと
結合させることで様々なペプチド基質も利用可能となっ
た。
[0004] As a substrate used in the in-gel phosphorylation method, a protein substrate such as myelin basic protein has conventionally been the mainstream, but it has been recently improved (Kameshita, I. and Fujisawa, H. et al.
(1996) Detection of protein kinase activities towar
d oligopeptides in sodium dodecyl sulfate-polyacry
Various peptide substrates can also be used by coupling a peptide serving as a substrate with an amino acid polymer such as polylysine by lamide gel. Anal. Biochem. 237, 198-203).

【0005】しかしながら、ゲル内リン酸化法において
も従来の蛋白・ペプチド基質を用いている限りはそれら
を基質として利用しうる特定の蛋白質リン酸化酵素の活
性しか検出できないという問題点は依然解決されていな
い。
[0005] However, the problem that the in-gel phosphorylation method can only detect the activity of a specific protein kinase capable of using them as a substrate as long as conventional protein / peptide substrates are used has been solved. Absent.

【0006】[0006]

【発明が解決しようとする課題】本発明は、リン酸化コ
ンセンサス配列を有するポリペプチド及びペプチドコン
ジュゲート及びそれを用いたSer/Thr蛋白質リン酸化酵
素の活性の同時検出及びスクリーニング方法を提供する
ことを目的とする。
SUMMARY OF THE INVENTION The present invention provides a polypeptide and a peptide conjugate having a phosphorylation consensus sequence and a method for simultaneous detection and screening of the activity of Ser / Thr protein kinase using the same. Aim.

【0007】[0007]

【課題を解決するための手段】本発明者はいくつかの代
表的なSer/Thr蛋白質リン酸化酵素が同時に認識するペ
プチド性基質を創製し、それをゲル内リン酸化法に応用
することでいくつかのSer/Thr蛋白質リン酸化酵素の活
性を同時に検出することが可能になることを見出した。
Means for Solving the Problems The present inventors have created peptide substrates that are recognized by several typical Ser / Thr protein kinases at the same time and applied them to the in-gel phosphorylation method. It has been found that it becomes possible to simultaneously detect the activity of the Ser / Thr protein kinase.

【0008】本法によれば様々な基質特異性を有するSe
r/Thr蛋白質リン酸化酵素を粗抽出液のレベルで簡便か
つ同時に検出できるので、基質特異性未知の新規Ser/Th
r蛋白質リン酸化酵素のスクリーニングにも威力を発揮
する。このような目的で代表的なSer/Thr蛋白質リン酸
化酵素(CaMKII、カルモジュリン依存性リン酸化酵素IV
(CaMKIV)、PKA、Protein kinaseC(PKC)、MAPK)が認識す
る5カ所のリン酸化コンセンサス配列を有することを特
徴とする、22個のアミノ酸が結合したペプチド(Multid
e)とMultideの5カ所のリン酸化コンセンサス配列のう
ち、一つずつリン酸化コンセンサス配列を有する5種類
のMultide類似ペプチド(Multide(5S), Multide(6S), Mu
ltide(11S), Multide(14T), Multide(19S))を創製し
た。またこれらをゲル内リン酸化法に応用すべく、poly
(Lys)またはpoly(Glu, Lys, Tyr)に結合させて各々のペ
プチドコンジュゲートを作製した。
According to this method, Se having various substrate specificities
r / Thr protein kinase can be easily and simultaneously detected at the level of crude extract, and new Ser / Th with unknown substrate specificity
r It is also effective in screening for protein kinases. Ser / Thr protein kinases (CaMKII, calmodulin-dependent kinase IV for this purpose)
(CaMKIV), PKA, protein kinase C (PKC), characterized by having a phosphorylation consensus sequence of five sites recognized by MAPK), a peptide (Multid
e) and five of the five phosphorylation consensus sequences of Multide, each of which has five phosphorylation consensus sequences, each of which has five phosphorylation consensus sequences (Multide (5S), Multide (6S), Mude
ltide (11S), Multide (14T), Multide (19S)) were created. To apply these to the in-gel phosphorylation method,
Each peptide conjugate was prepared by binding to (Lys) or poly (Glu, Lys, Tyr).

【0009】本発明は、下記のMultide、5種類のMultid
e類似ペプチド及びペプチドコンジュゲートに関する。
The present invention relates to the following Multide, five types of Multid
e For analogous peptides and peptide conjugates.

【0010】また、本発明は該ペプチドコンジュゲート
を用いたSer/Thr蛋白質リン酸化酵素の活性同時検出方
法及びスクリーニング方法に関する。 項1. 下記に示されるポリペプチド(Multide) Lys Lys Arg Lys Ser Ser Leu Arg Arg Trp Ser Pro Leu Thr Pro Arg Gln Met Ser Phe Asp Cys 項2. 下記に示されるポリペプチド(Multide(5S)) Lys Lys Arg Lys Ser Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys 項3. 下記に示されるポリペプチド(Multide(6S)) Lys Lys Arg Lys Ala Ser Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys 項4. 下記に示されるポリペプチド(Multide(11S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ser Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys 項5. 下記に示されるポリペプチド(Multide(14T)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Thr Pro Arg Gln Met Ala Phe Asp Cys 項6. 下記に示されるポリペプチド(Multide(19S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ser Phe Asp Cys 項7. 項1〜6のいずれかに記載のポリペプチドとア
ミノ酸ポリマーを結合したペプチドコンジュゲート。 項8. アミノ酸ポリマーがポリLysまたはポリ(Glu、
Lys、Tyr)である項7に記載のペプチドコンジュゲー
ト。 項9. 項1〜6のいずれかに記載のポリペプチド或い
は請求項7または8に記載のペプチドコンジュゲートを
使用することを特徴とするゲル内リン酸化法により少な
くとも2種のSer/Thr蛋白質リン酸化酵素の活性の同時
測定法。 項10. 項1〜6のいずれかに記載のポリペプチド或
いは請求項7または8に記載のペプチドコンジュゲート
を使用することを特徴とするゲル内リン酸化法による新
規Ser/Thr蛋白質リン酸化酵素のスクリーニング方法。
[0010] The present invention also relates to a method for simultaneous detection and screening of Ser / Thr protein kinase activity using the peptide conjugate. Item 1. Polypeptide shown below (Multide) Lys Lys Arg Lys Ser Ser Leu Arg Arg Trp Ser Pro Leu Thr Pro Arg Gln Met Ser Phe Asp Cys Item 2. Polypeptide shown below (Multide (5S)) Lys Lys Arg Lys Ser Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys Item 3. Polypeptide shown below (Multide (6S)) Lys Lys Arg Lys Ala Ser Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys Item 4. Polypeptide shown below (Multide (11S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ser Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys Item 5. Polypeptide shown below (Multide (14T)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Thr Pro Arg Gln Met Ala Phe Asp Cys Item 6. Polypeptide shown below (Multide (19S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ser Phe Asp Cys Item 7. Item 7. A peptide conjugate comprising the polypeptide according to any one of Items 1 to 6 and an amino acid polymer. Item 8. Amino acid polymer is poly Lys or poly (Glu,
8. The peptide conjugate according to item 7, which is Lys, Tyr). Item 9. Item 9. At least two types of Ser / Thr protein kinases by the in-gel phosphorylation method, wherein the polypeptide according to any one of items 1 to 6 or the peptide conjugate according to claim 7 or 8 is used. Simultaneous measurement of activity. Item 10. A method for screening a novel Ser / Thr protein kinase by the in-gel phosphorylation method, wherein the polypeptide according to any one of items 1 to 6 or the peptide conjugate according to claim 7 or 8 is used.

【0011】[0011]

【発明の実施の形態】発明に用いた方法 (i)[γ-32P]ATP(5000Ci/mmol)はアマーシャム社から購
入した。Poly(Lys)(平均分子量87000)、poly(Glu, Lys,
Tyr)(平均分子量23000)、Kemptide(LRRASLG)とmyelin
basic proteinはSigma社製を使用した。Recombinant mo
use p42MAPKとRecombinant human MEK1はUpstate Biote
chnology社製を使用した。一般的な蛋白質リン酸化酵素
阻害剤であるK252aはCalbiochem社から購入した。Mult
ide、5種類のMultide類似ペプチド(Multide(5S), Multi
de(6S), Multide(11S), Multide(14T), Multide(19S))
とSyntide-2(PLARTLSVAGLPGKK)は島津社製のペプチド固
相合成機PSSM8を使用し、fmocペプチド合成法により合
成した。合成したペプチドは逆相カラムクロマトグラフ
ィー(ODS-80Tm,トーソー社製)を用い、高速液体クロマ
トグラフィーにより精製した。ペプチドの分子量決定
は、fast atom bombardment-mass spectrometry質量分
析機を用い、分子量決定を行った。Poly(Lys)あるいはp
oly(Glu, Lys, Tyr)と、合成したペプチドを反応させて
ペプチドコンジュゲートを作成した(Kameshita, I. an
d Fujisawa, H. (1996) Detection of protein kinase
activities toward oligopeptides in sodium dodecyl
sulfate-polyacrylamide gel. Anal. Biochem. 237, 19
8-203)。カルモジュリンはラット精巣から精製した。C
aMKIIはラット大脳皮質から精製した。PKA(触媒サブユ
ニット)は牛心臓から精製した。 (ii)ヒト結腸由来のガン細胞であるColo201(non-adhere
nt colon adenocarcinoma cell line)をRPMI1640に10%
牛胎児血清とペニシリン、ストレプトマイシンを添加し
た培地で培養し、K252a(300 nM)を30分反応させた細胞
と未反応細胞を作成した。細胞は0℃で抽出緩衝液(20 m
M Tris-HCl(pH 7.4), 20 mM NaCl, 1 mM sodium orthov
anadate, 10 mM NaF, 5 mM sodium pyrophosphate, 0.5
mM EGTA,1 mM phenylmethylsulfonyl fluoride, 0.2
μM okadaic acid, 10 μg/ml leupeptin, 10 μg/ml a
ntipain, 10 μg/ml chymostatin, 10 μg/ml pepstati
n)に懸濁した。その後25ゲージの注射針に5回通し、細
胞破砕器(Olympus UC-100-D)で30秒間、4回破砕を行
った。破砕物は15000gで10分間遠心し、上清を細胞抽出
液とした。 (iii)Recombinant mouse p42MAPK(1 μg)は50 μlの以
下の反応液(50 mM Tris-HCl(pH 7.4), 10 mM MgCl2, 2
mM EGTA, 2 mM dithiothreitol, 50 μM ATP, 80ng rec
ombinant human MEK1)で30分、30℃で反応することによ
り活性化した。反応は10 mM EDTAかSDS bufferを加える
ことにより停止した。 (iv)各蛋白質リン酸化酵素の活性は30℃における[γ-32
P]ATP存在下での合成ペプチドへの1分間あたりの[32P]
リン酸の取り込み量をホスホセルロースペーパーを用い
るRoskoskiの方法(Roskoski, R. (1983)Assay of prot
ein kinases. Methods in Enzymology 99, 3-6)で測定
することにより算出した。各タンパク質リン酸化酵素の
活性測定反応液の組成は以下の通りである。 PKA;40 mM HEPES-NaOH(pH 8.0), 5 mM Mg(CH3COO)2,
0.1 mM EGTA, 2 mM dithiothreitol, 50 μM [γ-32P]A
TP(200-500 cpm/pmol), 0.01μg PKA, 20 μM oligopep
tide CaMKII;40mM HEPES-NaOH (pH8.0), 5 mM Mg(CH3COO)2,
0.1 mM EGTA, 2 mM dithiothreitol, 50 μM [γ-32P]
ATP(200-500 cpm/pmol), 0.2 mM CaCl2, 1 μM calmodu
lin, 0.01μg CaMKII, 20 μM oligopeptide (v)ゲル内リン酸化法は以下の様に行った。ポリアクリ
ルアミド電気泳動はSDS存在下でLaemmliの方法(Laemml
i, U. (1970)Cleavage of structural proteins during
the assembly of the head of bacteriophage T4. Nat
ure 227, 680-685)に従って行った。10 %アクリルアミ
ド分離用ゲルと3%のスタッキングゲルでスラブゲルを作
成した。20 μMペプチドコンジュゲート(20μg/ml poly
(Lys)あるいは20μg/ml poly(Glu, Lys, Tyr)にペプチ
ドを反応させて作成した。)を基質としてColo201細胞の
細胞抽出液(10 μg)を使用して、ゲル内リン酸化法を行
った。蛋白質リン酸化酵素の自己リン酸化反応を見る場
合、ペプチドコンジュゲート非存在下でゲル内リン酸化
反応を行った。リン酸化反応は、25度、2時間、2.5 ml
の反応液(50 mM Tris-HCl(pH 7.4), 10 mM MgCl2, 2 mM
EGTA, 2 mM dithiothreitol, 50 μM [γ-32P]ATP(10
μCi/ml)とミニゲル(8.5 x 4.5 x 0.1 cm)を反応させて
行った。CaMKIIの検出を行うときは、0.2 mM CaCl2と1
μM calmodulinを反応液に加えて行った。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Method (i) [γ- 32 P] ATP (5000 Ci / mmol) used in the invention was purchased from Amersham. Poly (Lys) (average molecular weight 87,000), poly (Glu, Lys,
Tyr) (average molecular weight 23000), Kemptide (LRRASLG) and myelin
The basic protein used was manufactured by Sigma. Recombinant mo
use p42MAPK and Recombinant human MEK1 are Upstate Biote
Chnology was used. K252a, a general protein kinase inhibitor, was purchased from Calbiochem. Mult
ide, 5 kinds of Multide-like peptides (Multide (5S), Multide
de (6S), Multide (11S), Multide (14T), Multide (19S))
And Syntide-2 (PLARTLSVAGLPGKK) were synthesized by fmoc peptide synthesis using a peptide solid phase synthesizer PSSM8 manufactured by Shimadzu Corporation. The synthesized peptide was purified by high performance liquid chromatography using reverse phase column chromatography (ODS-80Tm, manufactured by Tosoh Corporation). The molecular weight of the peptide was determined using a fast atom bombardment-mass spectrometry mass spectrometer. Poly (Lys) or p
oly (Glu, Lys, Tyr) was reacted with the synthesized peptide to form a peptide conjugate (Kameshita, I. an
d Fujisawa, H. (1996) Detection of protein kinase
activities toward oligopeptides in sodium dodecyl
Sulfate-polyacrylamide gel.Analyte. Biochem. 237, 19
8-203). Calmodulin was purified from rat testis. C
aMKII was purified from rat cerebral cortex. PKA (catalytic subunit) was purified from bovine heart. (ii) Colo201 (non-adhere) which is a cancer cell derived from human colon
nt colon adenocarcinoma cell line) to RPMI1640 10%
The cells were cultured in a medium supplemented with fetal calf serum, penicillin and streptomycin, and cells reacted with K252a (300 nM) for 30 minutes and unreacted cells were prepared. Cells are incubated at 0 ° C in extraction buffer (20 m
M Tris-HCl (pH 7.4), 20 mM NaCl, 1 mM sodium orthov
anadate, 10 mM NaF, 5 mM sodium pyrophosphate, 0.5
mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 0.2
μM okadaic acid, 10 μg / ml leupeptin, 10 μg / ml a
ntipain, 10 μg / ml chymostatin, 10 μg / ml pepstati
n). Thereafter, the mixture was passed through a 25-gauge injection needle five times, and crushed four times for 30 seconds using a cell disrupter (Olympus UC-100-D). The crushed product was centrifuged at 15000 g for 10 minutes, and the supernatant was used as a cell extract. (iii) Recombinant mouse p42MAPK (1 μg) is 50 μl of the following reaction mixture (50 mM Tris-HCl (pH 7.4), 10 mM MgCl 2 , 2
mM EGTA, 2 mM dithiothreitol, 50 μM ATP, 80ng rec
It was activated by reacting with ombinant human MEK1) for 30 minutes at 30 ° C. The reaction was stopped by adding 10 mM EDTA or SDS buffer. (iv) The activity of each protein kinase is 30 ° C [γ- 32
[ 32 P] per minute to synthetic peptide in the presence of [P] ATP
Phosphoric acid uptake was determined by the method of Roskoski using phosphocellulose paper (Roskoski, R. (1983) Assay of prot.
It was calculated by measuring with ein kinases. Methods in Enzymology 99, 3-6). The composition of the reaction solution for measuring the activity of each protein kinase is as follows. PKA: 40 mM HEPES-NaOH (pH 8.0), 5 mM Mg (CH 3 COO) 2 ,
0.1 mM EGTA, 2 mM dithiothreitol, 50 μM [γ- 32 P] A
TP (200-500 cpm / pmol), 0.01 μg PKA, 20 μM oligopep
tide CaMKII; 40 mM HEPES-NaOH (pH 8.0), 5 mM Mg (CH 3 COO) 2 ,
0.1 mM EGTA, 2 mM dithiothreitol, 50 μM [γ- 32 P]
ATP (200-500 cpm / pmol), 0.2 mM CaCl 2 , 1 μM calmodu
lin, 0.01 μg CaMKII, 20 μM oligopeptide (v) In-gel phosphorylation was performed as follows. Polyacrylamide gel electrophoresis was performed using the Laemmli method (Laemml
i, U. (1970) Cleavage of structural proteins during
the assembly of the head of bacteriophage T4. Nat
ure 227, 680-685). A slab gel was prepared using 10% acrylamide separation gel and 3% stacking gel. 20 μM peptide conjugate (20 μg / ml poly
(Lys) or 20 μg / ml poly (Glu, Lys, Tyr) was made to react with the peptide. ) Was used as a substrate to perform an in-gel phosphorylation method using a cell extract (10 μg) of Colo201 cells. When looking at the autophosphorylation of protein kinase, the phosphorylation in gel was performed in the absence of peptide conjugate. Phosphorylation reaction, 25 degrees, 2 hours, 2.5 ml
Reaction solution (50 mM Tris-HCl (pH 7.4), 10 mM MgCl 2 , 2 mM
EGTA, 2 mM dithiothreitol, 50 μM [γ- 32 P] ATP (10
μCi / ml) and minigel (8.5 × 4.5 × 0.1 cm). When detecting CaMKII, 0.2 mM CaCl 2 and 1 mM
μM calmodulin was added to the reaction solution.

【0012】[0012]

【発明の効果】MultideはSer/Thr蛋白質リン酸化酵素が
認識する5カ所のリン酸化コンセンサス配列を有するこ
とを特徴とする、22個のアミノ酸が結合したペプチドで
ある。Multideの5カ所のリン酸化コンセンサス配列の
うち、一つずつリン酸化コンセンサス配列を有する5種
類のMultide類似ペプチド(Multide(5S), Multide(6S),
Multide(11S), Multide(14T), Multide(19S))とMultide
を同時にゲル内リン酸化法と組み合わせて使用すること
により、カルモジュリン依存性リン酸化酵素II(CaMKI
I)、cyclic AMP依存性リン酸化酵素(PKA)、mitogen-act
ivated protein kinase (MAPK)などのSer/Thr蛋白質リ
ン酸化酵素の細胞内での活性を一度にかつ同時に検出で
きる。また本法により、新規Ser/Thr蛋白質リン酸化酵
素のスクリーニングが可能である。
According to the present invention, Multide is a peptide having 22 amino acids bonded, which has five phosphorylation consensus sequences recognized by Ser / Thr protein kinase. Among the five phosphorylation consensus sequences of Multide, five kinds of Multide-like peptides each having a phosphorylation consensus sequence (Multide (5S), Multide (6S),
Multide (11S), Multide (14T), Multide (19S)) and Multide
Can be used in combination with the in-gel phosphorylation method to achieve calmodulin-dependent kinase II (CaMKI
I), cyclic AMP-dependent kinase (PKA), mitogen-act
The intracellular activity of Ser / Thr protein kinase such as ivated protein kinase (MAPK) can be detected at once and simultaneously. In addition, this method enables screening of novel Ser / Thr protein kinases.

【0013】[0013]

【実施例】以下、本発明を実施例に基づきより詳細に説
明する。 実施例1 Multide(KKRKSSLRRWSPLTPRQMSFDC)は5つのSer/Thr蛋白
質リン酸化酵素(CaMKII, CaMKIV, PKA, PKC, MAPK)が認
識する5カ所のリン酸化コンセンサス配列を有すること
を特徴とする、22個のアミノ酸が結合したペプチドであ
る。Multideのリン酸化部位の解析のためにMultideの5
カ所のリン酸化コンセンサス配列のうち、一つずつリン
酸化コンセンサス配列を有する5種類のMultide類似ペプ
チド(Multide(5S), Multide(6S), Multide(11S), Multi
de(14T), Multide(19S))を合成した(図1)。Multideと
5種類のMultide類似ペプチドのPKAとCaMKIIによるリン
酸化の度合いを調べるために、これらのペプチド基質と
してよく用いられる、Kemptide(LRRASLG)とSyntide-2(P
LARTLSVAGLPGKK)を同時に使用して、PKAとCaMKIIによる
リン酸化(in vitro kinase assay)を調べた(表1)。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in more detail with reference to embodiments. Example 1 Multide (KKRKSSLRRWSPLTPRQMSFDC) is characterized by having five phosphorylation consensus sequences recognized by five Ser / Thr protein kinases (CaMKII, CaMKIV, PKA, PKC, MAPK), 22 amino acids Is a peptide bound. Multide 5 for analysis of Multide phosphorylation sites
Among the phosphorylation consensus sequences at five sites, five types of Multide-like peptides each having a phosphorylation consensus sequence (Multide (5S), Multide (6S), Multide (11S), Multide
de (14T) and Multide (19S)) were synthesized (FIG. 1). Multide and
In order to examine the degree of phosphorylation of five kinds of Multide-like peptides by PKA and CaMKII, Kemptide (LRRASLG) and Syntide-2 (P
LARTLSVAGLPGKK) was simultaneously used to examine phosphorylation (in vitro kinase assay) by PKA and CaMKII (Table 1).

【0014】[0014]

【表1】 [Table 1]

【0015】MultideとMultide(6S)はPKAにより強くリ
ン酸化されたが、Multide(5S)、Multide(11S)、Multide
(19S)は弱くしかリン酸化されなかった。さらにMultide
(14T)はPKAにより、全くリン酸化されなかった。一方、
MultideとMultide(19S)はCaMKIIによりリン酸化された
が、Syntide-2よりはリン酸化の度合いは低かった。
Although Multide and Multide (6S) were strongly phosphorylated by PKA, Multide (5S), Multide (11S),
(19S) was weakly phosphorylated. Multide
(14T) was not phosphorylated at all by PKA. on the other hand,
Multide and Multide (19S) were phosphorylated by CaMKII, but to a lesser extent than Syntide-2.

【0016】またペプチドをpoly(Lys)あるいはpoly(Gl
u, Lys, Tyr)などのポリマーに結合させるとゲル内に保
持できるだけでなく、蛋白質リン酸化酵素の良好な基質
となることがわかっている(Kameshita, I. and Fujisa
wa, H. (1996)Detection ofprotein kinase activities
toward oligopeptides in sodium dodecyl sulfate-po
lyacrylamide gel. Anal. Biochem. 237, 198-203;Kam
eshita, I., Ishida,A. and Fujisawa, H. (1997)A new
peptide conjugate as a highly specificsubstrate f
or MAP kinase. J. Biochem., 122, 168-172)。そこで
Multideと5種類のMultide類似ペプチド(Multide(5S), M
ultide(6S), Multide(11S), Multide(14T), Multide(19
S))をpoly(Lys)に結合させた物(Multide-poly(Lys))を
作成し、ゲル内リン酸化法に使用した。Multide-poly(L
ys)を基質としてPKAを使用し、ゲル内リン酸化反応を行
った(図2A)。その結果PKAの触媒サブユニット(41 kD
a)に相当する分子量の位置に強いリン酸化産物が認めら
れた。Multide(6S)-poly(Lys)を基質にした時も強いリ
ン酸化が認められたことから、PKAによるリン酸化は主
にSer6であることがわかった。またCaMKIIの場合、Mult
ide-poly(Lys)とMultide(19S)-poly(Lys)を基質として
使用した時にのみ、αサブユニット(50 kDa)とβサブユ
ニット(60 kDa)に相当する所にふたつのリン酸化産物が
認められた(図2、B)。MAPKの場合、MEKにより活性化
したMAPKを使用して、ゲル内リン酸化反応を行った。Mu
ltide-poly(Lys)、Multide(14T)-poly(Lys)に強いリン
酸化が認められた。以上の結果はPro-Xaa-Ser/Thr-Pro
がMAPKのリン酸化コンセンサス配列であるという報告と
一致する。
The peptide may be poly (Lys) or poly (Gl
u, Lys, Tyr) have been shown not only to be retained in gels but also to be good substrates for protein kinases (Kameshita, I. and Fujisa
wa, H. (1996) Detection of protein kinase activities
toward oligopeptides in sodium dodecyl sulfate-po
lyacrylamide gel. Anal. Biochem. 237, 198-203; Kam
eshita, I., Ishida, A. and Fujisawa, H. (1997) A new
peptide conjugate as a highly specificsubstrate f
or MAP kinase. J. Biochem., 122, 168-172). Therefore
Multide and 5 Multide-like peptides (Multide (5S), M
ultide (6S), Multide (11S), Multide (14T), Multide (19
(S)) was linked to poly (Lys) to prepare a product (Multide-poly (Lys)), which was used for the in-gel phosphorylation method. Multide-poly (L
In-gel phosphorylation was performed using PKA as a substrate (ys) (FIG. 2A). As a result, the catalytic subunit of PKA (41 kD
A strong phosphorylation product was observed at the position of the molecular weight corresponding to a). Multide the (6S) -poly (Lys) from the even stronger phosphorylation when the substrate was observed, it was found that phosphorylation by PKA is mainly Ser 6. In case of CaMKII, Mult
Only when ide-poly (Lys) and Multide (19S) -poly (Lys) were used as substrates, two phosphorylation products were found at the positions corresponding to the α subunit (50 kDa) and β subunit (60 kDa). (Figure 2, B). In the case of MAPK, a phosphorylation reaction in a gel was performed using MAPK activated by MEK. Mu
Strong phosphorylation was observed in ltide-poly (Lys) and Multide (14T) -poly (Lys). These results are for Pro-Xaa- Ser / Thr -Pro
Is a phosphorylation consensus sequence of MAPK.

【0017】上記の結果からMultideと5種類のMultide
類似ペプチドをゲル内リン酸化法で使用すれば、細胞内
の新規蛋白質リン酸化酵素のスクリーニングに使用でき
ると考えられた。ヒト結腸由来のガン細胞であるColo20
1を蛋白質リン酸化酵素阻害剤であるK252aで処理すると
30分後に細胞形態が急激に変化することが知られている
(Mohri, T., Kameshita, I., Suzuki, S., Hioki, K.,
Tokunaga, R. andTaketani, S. (1998) Rapid adhesio
n and spread of non-adherent colon cancer Colo201
cells induced by the protein kinase inhibitors, K2
52a and KT5720 and suppression of the adhesion by
the immunosuppressants FK506 andcyclosporin A. Cel
l Struct. Funct. 23, 255-264)。つまり蛋白質リン酸
化酵素の阻害により本細胞の形態変化が引き起こされる
ことから、形態変化前後での蛋白質リン酸化酵素の変化
を調べることにした。そこでMultideと5種類のMultide
類似ペプチドを使用し、ゲル内リン酸化反応を行った
(図3)。poly(Lys)をポリマー支持体として使用した場
合、PKAのリン酸化のバンドが強く出すぎることから、p
oly(Glu, Lys, Tyr)をポリマー支持体として使用した。
Multide-poly(Glu, Lys, Tyr)を基質として使用した場
合、K252a処理後に、29 kDa、50 kDa、90kDaのリン酸化
のバンドが減少した。一方、60 kDa(doublet)、76 kD
a、150 kDaのバンドが増大した。150 kDaのバンドはMul
tide(5S)-poly(Glu, Lys, Tyr)を基質としたときに弱い
バンドが認められたが、60 kDa(doublet)のバンドはMul
tide(5S)-poly(Glu, Lys, Tyr)とMultide(6S)-poly(Gl
u, Lys, Tyr)を両方基質にした際にも認められた。以上
の結果から二つの蛋白質リン酸化酵素は異なる基質特異
性を有することがわかった。一方、76 kDaのバンドは基
質が存在しない場合にもバンドが認められることから、
自己リン酸化を起こしていることがわかった。K252a処
理後に減少した90 kDaのバンドはMultide-poly(Glu, Ly
s, Tyr)とMultide(6S)-poly(Glu, Lys, Tyr)を両方基質
にした際にも認められたことから、PKAと同様な基質特
異性を有していることがわかった。50 kDaのバンドはMu
ltide-poly(Glu, Lys, Tyr)、Multide(5S)-poly(Glu, L
ys, Tyr)、Multide(6S)-poly(Glu,Lys, Tyr)、Multide
(19S)-poly(Glu, Lys, Tyr)をいずれも基質にした際に
もバンドは認められた。
From the above results, Multide and five types of Multide
It was considered that the use of a similar peptide by the in-gel phosphorylation method could be used for screening for a novel protein kinase in cells. Colo20, a human colon-derived cancer cell
Treatment of 1 with K252a, a protein kinase inhibitor
It is known that the cell morphology changes rapidly after 30 minutes (Mohri, T., Kameshita, I., Suzuki, S., Hioki, K.,
Tokunaga, R. andTaketani, S. (1998) Rapid adhesio
n and spread of non-adherent colon cancer Colo201
cells induced by the protein kinase inhibitors, K2
52a and KT5720 and suppression of the adhesion by
the immunosuppressants FK506 andcyclosporin A. Cel
l Struct. Funct. 23, 255-264). In other words, since the inhibition of the protein kinase causes a morphological change of the present cells, the change in the protein kinase before and after the morphological change was determined. So Multide and 5 kinds of Multide
In-gel phosphorylation was performed using a similar peptide (FIG. 3). When poly (Lys) was used as the polymer support, the phosphorylation band of PKA was too strong, so p
oly (Glu, Lys, Tyr) was used as the polymer support.
When Multide-poly (Glu, Lys, Tyr) was used as a substrate, the phosphorylation bands of 29 kDa, 50 kDa, and 90 kDa were reduced after K252a treatment. On the other hand, 60 kDa (doublet), 76 kD
a, 150 kDa band increased. The 150 kDa band is Mul
A weak band was observed when tide (5S) -poly (Glu, Lys, Tyr) was used as a substrate, but the band of 60 kDa (doublet) was
tide (5S) -poly (Glu, Lys, Tyr) and Multide (6S) -poly (Gl
u, Lys, Tyr) were also observed when both were used as substrates. These results indicate that the two protein kinases have different substrate specificities. On the other hand, the band of 76 kDa is observed even when the substrate is not present.
It was found that autophosphorylation was occurring. The 90 kDa band reduced after K252a treatment was Multide-poly (Glu, Ly
s, Tyr) and Multide (6S) -poly (Glu, Lys, Tyr) were both used as substrates, indicating that they had the same substrate specificity as PKA. 50 kDa band is Mu
ltide-poly (Glu, Lys, Tyr), Multide (5S) -poly (Glu, L
ys, Tyr), Multide (6S) -poly (Glu, Lys, Tyr), Multide
A band was also observed when (19S) -poly (Glu, Lys, Tyr) was used as a substrate.

【0018】以上の結果から、Ser/Thr蛋白質リン酸化
酵素(CaMKII、CaMKIV、PKA、PKC、MAPK)が認識する5カ
所のリン酸化コンセンサス配列を有することを特徴とす
る、22個のアミノ酸が結合したMultideペプチドと、Mul
tideの5カ所のリン酸化コンセンサス配列のうち、一つ
ずつリン酸化コンセンサス配列を有する5種類のMultide
類似ペプチド(Multide(5S), Multide(6S), Multide(11
S), Multide(14T), Multide(19S))をペプチドコンジュ
ゲートとしてゲル内リン酸化法に応用することで同時に
いくつかのSer/Thr蛋白質リン酸化酵素の活性を検出す
ることが可能であることがわかった。本法は基質特異性
未知の新規Ser/Thr蛋白質リン酸化酵素のスクリーニン
グにも有用であると思われる。
From the above results, 22 amino acids, which are characterized by having five phosphorylation consensus sequences recognized by Ser / Thr protein kinase (CaMKII, CaMKIV, PKA, PKC, MAPK) Multide peptide and Mul
Among the five phosphorylation consensus sequences of tide, five types of Multide having phosphorylation consensus sequences one by one
Similar peptides (Multide (5S), Multide (6S), Multide (11
(S), Multide (14T), Multide (19S)) as a peptide conjugate can be applied to the in-gel phosphorylation method to simultaneously detect the activity of several Ser / Thr protein kinases I understood. This method is also useful for screening novel Ser / Thr protein kinases with unknown substrate specificity.

【0019】[0019]

【配列表】 <110>Koji Kajimura:Director General, Agency of Industrial Science and Te chnology <120>Polypeptides and peptide-conjugates (130>113MS0235 <160>6 <210>1 <211>22 <212>PRT <213>Artificial Sequence <400>1 Lys Lys Arg Lys Ser Ser Leu Arg Arg Trp Ser Pro Leu Thr Pro Arg 1 5 10 15 Gln Met Ser Phe Asp Cys 20 22 <210>2 <211>22 <212>PRT <213>Artificial Sequence <400>2 Lys Lys Arg Lys Ser Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210>3 <211>22 <212>PRT <213>Artificial Sequence <400>3 Lys Lys Arg Lys Ala Ser Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210>4 <211>22 <212>PRT <213>Artificial Sequence <400>4 Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ser Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210>5 <211>22 <212>PRT <213>Artificial Sequence <400>5 Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Thr Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210>6 <211>22 <212>PRT <213>Artificial Sequence <400>6 Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ser Phe Asp Cys 20 22[Sequence List] <110> Koji Kajimura: Director General, Agency of Industrial Science and Technology <120> Polypeptides and peptide-conjugates (130> 113MS0235 <160> 6 <210> 1 <211> 22 <212> PRT <213 > Artificial Sequence <400> 1 Lys Lys Arg Lys Ser Ser Leu Arg Arg Trp Ser Pro Leu Thr Pro Arg 1 5 10 15 Gln Met Ser Phe Asp Cys 20 22 <210> 2 <211> 22 <212> PRT <213> Artificial Sequence <400> 2 Lys Lys Arg Lys Ser Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210> 3 <211> 22 <212> PRT <213> Artificial Sequence <400> 3 Lys Lys Arg Lys Ala Ser Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210> 4 <211> 22 <212> PRT <213> Artificial Sequence <400> 4 Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ser Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210> 5 <211> 22 <212> PRT <213> Artificial Sequence < 400> 5 Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Thr Pro Arg 1 5 10 15 Gln Met Ala Phe Asp Cys 20 22 <210> 6 <211> 22 <212> PRT <213> Artificial Sequence <400> 6 Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg 1 5 10 15 Gln Met Ser Phe Asp Cys 20 22

【図面の簡単な説明】[Brief description of the drawings]

【図1】Multide及び5種類のMultide類似ペプチド(Mult
ide(5S), Multide(6S),Multide(11S), Multide(14T), M
ultide(19S))のアミノ酸配列とそのリン酸化部位を示
す。なお、図1中の配列の下線部は、各蛋白質リン酸化
酵素のリン酸化部位を示す。
FIG. 1: Multide and five Multide-like peptides (Mult
ide (5S), Multide (6S), Multide (11S), Multide (14T), M
2 shows the amino acid sequence of C. ultide (19S)) and its phosphorylation site. The underlined part of the sequence in FIG. 1 indicates the phosphorylation site of each protein kinase.

【図2】PKAとCaMKII とMAPK によるMultide及び5種類
のMultide類似ペプチド(Multide(5S), Multide(6S), Mu
ltide(11S), Multide(14T), Multide(19S))のゲル内リ
ン酸化を示す。PKA(20ng)(A)、CaMKII(250ng)(B) 及び
活性化MAPK-GST(20ng)(C)の精製調製物は、20μg/mlポ
リ(Lys)(レ−ン1)、20μM Multideポリ(Lys)(レーン
2)、20μM Multide(5S)-ポリ(Lys)(レーン3)、20μM
Multide(6S)-ポリ(Lys)(レーン4)、20μM Multide(11
S)-ポリ(Lys)(レーン5)、20μM Multide(14T)-ポリ(Ly
s)(レーン6)、20μM Multide(19S)-ポリ(Lys)(レーン
7)を基質として含むSDS−ポリアクリルアミドゲル
電気泳動を行った。
FIG. 2: Multide by PKA, CaMKII and MAPK and 5 kinds of Multide-like peptides (Multide (5S), Multide (6S), Mude
1 shows phosphorylation in gel of ltide (11S), Multide (14T) and Multide (19S)). Purified preparations of PKA (20 ng) (A), CaMKII (250 ng) (B) and activated MAPK-GST (20 ng) (C) were prepared at 20 μg / ml poly (Lys) (lane 1), 20 μM Multide poly (Lys) (lane 2), 20 μM Multide (5S) -poly (Lys) (lane 3), 20 μM
Multide (6S) -poly (Lys) (lane 4), 20 μM Multide (11
(S) -poly (Lys) (lane 5), 20 μM Multide (14T) -poly (Ly
s) (lane 6) and SDS-polyacrylamide gel electrophoresis using 20 μM Multide (19S) -poly (Lys) (lane 7) as a substrate.

【図3】Colo201細胞(K252a処理(+)、及び未処理(-))
での、ゲル内リン酸化法とMultide及びMultide類似ペプ
チドを使用した、新規蛋白質リン酸化酵素の検出を示
す。Colo201細胞はK252aで30分間処理され、冷PBSで洗
浄され、遠心分離により集めた。K252a処理細胞(+)また
は未処理細胞(-)由来の粗抽出物(10μg)は、20μg/mlポ
リ(Glu,Lys,Tyr)(A)、20μM Multideポリ(Glu,Lys,Tyr)
(B),20μM Multide(5S)-ポリ(Glu,Lys,Tyr)(C)、20μM
Multide(6S)-ポリ(Glu,Lys,Tyr)(D)、20μM Multide(11
S)-ポリ(Glu,Lys,Tyr)(E)、20μM Multide(14T)-ポリ(G
lu,Lys,Tyr)(F)、20μM Multide(19S)-ポリ(Glu,Lys,Ty
r)(G)を基質として含む、或いは基質なし(H)のSDS−
ポリアクリルアミドゲル電気泳動を行った。ゲル右側の
「△」は、K252a処理後に増加した蛋白質キナーゼ活性
を示し、ゲル左側の「▼」は、K252a処理後に減少した
蛋白質キナーゼ活性を示す。
FIG. 3 Colo201 cells (K252a-treated (+) and untreated (-))
2 shows the detection of a novel protein kinase using the in-gel phosphorylation method and Multide and Multide-like peptides. Colo201 cells were treated with K252a for 30 minutes, washed with cold PBS, and collected by centrifugation. Crude extract (10 μg) derived from K252a-treated cells (+) or untreated cells (−) was 20 μg / ml poly (Glu, Lys, Tyr) (A), 20 μM Multide poly (Glu, Lys, Tyr)
(B), 20 μM Multide (5S) -poly (Glu, Lys, Tyr) (C), 20 μM
Multide (6S) -poly (Glu, Lys, Tyr) (D), 20 μM Multide (11
(S) -poly (Glu, Lys, Tyr) (E), 20 μM Multide (14T) -poly (G
lu, Lys, Tyr) (F), 20 μM Multide (19S) -poly (Glu, Lys, Ty
r) SDS containing (G) as a substrate or without substrate (H)
Polyacrylamide gel electrophoresis was performed. "△" on the right side of the gel indicates increased protein kinase activity after K252a treatment, and "▼" on the left side of gel indicates decreased protein kinase activity after K252a treatment.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 石田 敦彦 北海道旭川市西神楽4線5号 旭川医科 大学内 (72)発明者 亀下 勇 北海道旭川市西神楽4線5号 旭川医科 大学内 (72)発明者 藤澤 仁 北海道旭川市西神楽4線5号 旭川医科 大学内 (56)参考文献 J.Biochem.(1999),126, p.991−995 J.Biol.Chem.(1991), 226(33),p.22159−22163 J.Biol.Chem.(1991), 226(23),p.15180−15184 FEBS Lett.(1999 Au g.),456(2),p.249−252 Anal.Biochem. (1996),237(2),p.198−203 J.Biochem.(Tokyo) (1997),122(1),p.168−172 J.Biochem.(1990),265 (32),p.19728−19735 (58)調査した分野(Int.Cl.7,DB名) C07K 14/00 C12Q 1/48 Geneseq/FASTA/DDBJ MEDLINE(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Atsuhiko Ishida, Asahikawa City, Hokkaido Asahikawa Medical University (72) Person Hitoshi Fujisawa Nishi Kagura 4-5, Asahikawa City, Hokkaido Asahikawa Medical University (56) References Biochem. (1999), 126, p. 991-995 J.P. Biol. Chem. (1991), 226 (33), p. 22159-22163 J.C. Biol. Chem. (1991), 226 (23), p. 15180-15184 FEBS Lett. (1999 Aug.), 456 (2), p. 249-252 Anal. Biochem. (1996), 237 (2), p. 198-203 Biochem. (Tokyo) (1997), 122 (1), p. 168-172 J.C. Biochem. (1990), 265 (32), p. 19728-19735 (58) Fields investigated (Int. Cl. 7 , DB name) C07K 14/00 C12Q 1/48 Geneseq / FASTA / DDBJ Medline (STN) REGISTRY (STN)

Claims (10)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】下記に示されるポリペプチド(Multide) Lys Lys Arg Lys Ser Ser Leu Arg Arg Trp Ser Pro Leu Thr Pro Arg Gln Met Ser Phe Asp Cys1. Polypeptide (Multide) Lys Lys Arg Lys Ser Ser Leu Arg Arg Trp Ser Pro Leu Thr Pro Arg Gln Met Ser Phe Asp Cys 【請求項2】下記に示されるポリペプチド(Multide(5
S)) Lys Lys Arg Lys Ser Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys
2. The polypeptide shown below (Multide (5
S)) Lys Lys Arg Lys Ser Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys
【請求項3】下記に示されるポリペプチド(Multide(6
S)) Lys Lys Arg Lys Ala Ser Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys
3. The polypeptide shown below (Multide (6
S)) Lys Lys Arg Lys Ala Ser Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys
【請求項4】下記に示されるポリペプチド(Multide(11
S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ser Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys
4. The polypeptide shown below (Multide (11
S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ser Pro Leu Ala Pro Arg Gln Met Ala Phe Asp Cys
【請求項5】下記に示されるポリペプチド(Multide(14
T)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Thr Pro Arg Gln Met Ala Phe Asp Cys
5. A polypeptide shown below (Multide (14
T)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Thr Pro Arg Gln Met Ala Phe Asp Cys
【請求項6】下記に示されるポリペプチド(Multide(19
S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ser Phe Asp Cys
6. A polypeptide shown below (Multide (19
S)) Lys Lys Arg Lys Ala Ala Leu Arg Arg Trp Ala Pro Leu Ala Pro Arg Gln Met Ser Phe Asp Cys
【請求項7】請求項1〜6のいずれかに記載のポリペプ
チドとアミノ酸ポリマーを結合したペプチドコンジュゲ
ート。
7. A peptide conjugate comprising the polypeptide according to claim 1 and an amino acid polymer.
【請求項8】アミノ酸ポリマーがポリLysまたはポリ(G
lu、Lys、Tyr)である請求項7に記載のペプチドコンジ
ュゲート。
8. The amino acid polymer is poly-Lys or poly (G
lu, Lys, Tyr).
【請求項9】請求項1〜6のいずれかに記載のポリペプ
チド或いは請求項7または8に記載のペプチドコンジュ
ゲートを使用することを特徴とするゲル内リン酸化法に
より少なくとも2種のSer/Thr蛋白質リン酸化酵素の活
性の同時測定法。
9. A method according to claim 1, wherein at least two types of Ser / S are prepared by using the polypeptide according to any one of claims 1 to 6 or the peptide conjugate according to claim 7 or 8. Simultaneous measurement of Thr protein kinase activity.
【請求項10】請求項1〜6のいずれかに記載のポリペ
プチド或いは請求項7または8に記載のペプチドコンジ
ュゲートを使用することを特徴とするゲル内リン酸化法
による新規Ser/Thr蛋白質リン酸化酵素のスクリーニン
グ方法。
10. A novel Ser / Thr protein phosphor by an in-gel phosphorylation method, wherein the polypeptide according to any one of claims 1 to 6 or the peptide conjugate according to claim 7 or 8 is used. An oxidase screening method.
JP11320437A 1999-11-11 1999-11-11 Polypeptide Expired - Lifetime JP3066502B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11320437A JP3066502B1 (en) 1999-11-11 1999-11-11 Polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11320437A JP3066502B1 (en) 1999-11-11 1999-11-11 Polypeptide

Publications (2)

Publication Number Publication Date
JP3066502B1 true JP3066502B1 (en) 2000-07-17
JP2001139598A JP2001139598A (en) 2001-05-22

Family

ID=18121447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11320437A Expired - Lifetime JP3066502B1 (en) 1999-11-11 1999-11-11 Polypeptide

Country Status (1)

Country Link
JP (1) JP3066502B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4956816B2 (en) * 2005-06-29 2012-06-20 国立大学法人 香川大学 Anti-tyrosine kinase antibody and use thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Anal.Biochem.(1996),237(2),p.198−203
FEBS Lett.(1999 Aug.),456(2),p.249−252
J.Biochem.(1990),265(32),p.19728−19735
J.Biochem.(1999),126,p.991−995
J.Biochem.(Tokyo)(1997),122(1),p.168−172
J.Biol.Chem.(1991),226(23),p.15180−15184
J.Biol.Chem.(1991),226(33),p.22159−22163

Also Published As

Publication number Publication date
JP2001139598A (en) 2001-05-22

Similar Documents

Publication Publication Date Title
Ahn et al. Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells.
Cheng et al. An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase
Thomas et al. Substrate-and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP.
Pike et al. Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes.
Kia-Ki et al. Post-translational chemical modification (s) of proteins
Molinari et al. Calpain: a cytosolic proteinase active at the membranes
Ahn et al. Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah)
Marmstål et al. Comparison of glyoxalase I purified from yeast (Saccharomyces cerevisiae) with the enzyme from mammalian sources
Dent et al. Multisite phosphorylation of the glycogen‐binding subunit of protein phosphatase‐1G by cyclic AMP‐dependent protein kinase and glycogen synthase kinase‐3
Hill et al. Lysophosphatidic acid inhibits gap-junctional communication and stimulates phosphorylation of connexin-43 in WB cells: possible involvement of the mitogen-activated protein kinase cascade
Hale et al. CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215
Hanada et al. Structure-function relationship of Atg12, a ubiquitin-like modifier essential for autophagy
Nakagomi et al. Isolation of Acein-2, a novel angiotensin-I-converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma
Wong et al. Purification and characterization of a galactose-specific lectin with mitogenic activity from pinto beans
Mayadevi et al. Sequence determinants on the NR2A and NR2B subunits of NMDA receptor responsible for specificity of phosphorylation by CaMKII
Hartshorne et al. Interactions of protein phosphatase type 1, with a focus on myosin phosphatase
Kuo et al. Molecular and physiopathologic aspects of mammalian cyclic GMP-dependent protein kinase
US8530421B2 (en) Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis
Belyanskaya et al. Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process
JP3066502B1 (en) Polypeptide
Shao et al. Characterization and mutational studies of equine infectious anemia virus dUTPase
Amici et al. Homogeneous pyrimidine nucleotidase from human erythrocytes: enzymic and molecular properties
MULLAPUDI et al. DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells
Xie et al. MNDA dimerizes through a complex motif involving an N-terminal basic region
Presek et al. High-yield purification of a pp60c-src related protein-tyrosine kinase from human platelets

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
R150 Certificate of patent or registration of utility model

Ref document number: 3066502

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term